Therapeutic Pretargeting with Gold Nanoparticles as Drug Candidates for Boron Neutron Capture Therapy

Autor: Feiner, IVJ, Pulagam, KR, Gómez‐Vallejo, V, Zamacola, K, Baz, Z, Caffarel, MM, Lawrie, CH, Ruiz‐de‐Angulo, A, Carril, M, Llop, J.

Boron neutron capture therapy (BNCT) is a binary approach for cancer treatment in which boron-10 atoms and thermal neutrons need to colocalize to become effective. Recent research in the development of BNCT drug candidates focuses increasingly on nan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2659::56c07e35951ab5332885bc1bd3803797
https://zenodo.org/record/4556861

Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability.

Autor: Guarrochena X; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.; Vienna Doctoral School in Chemistry, University of Vienna, Währinger Straße 42, 1090 Vienna, Austria.; Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Währinger Gürtel 18-20, 1090 Vienna, Austria.; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria., Kanellopoulos P; Molecular Radiopharmacy, INRaSTES, NCSR 'Demokritos', 15341 Athens, Greece., Stingeder A; Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Währinger Gürtel 18-20, 1090 Vienna, Austria.; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria., Rečnik LM; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.; Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Währinger Gürtel 18-20, 1090 Vienna, Austria.; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria., Feiner IVJ; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.; Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Währinger Gürtel 18-20, 1090 Vienna, Austria.; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria., Brandt M; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.; Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Währinger Gürtel 18-20, 1090 Vienna, Austria.; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria., Kandioller W; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria., Maina T; Molecular Radiopharmacy, INRaSTES, NCSR 'Demokritos', 15341 Athens, Greece., Nock BA; Molecular Radiopharmacy, INRaSTES, NCSR 'Demokritos', 15341 Athens, Greece., Mindt TL; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.; Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Währinger Gürtel 18-20, 1090 Vienna, Austria.; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria.; Joint Applied Medicinal Radiochemistry Facility, University of Vienna and Medical University of Vienna, 1090 Vienna, Austria.

Publikováno v: Pharmaceutics [Pharmaceutics] 2024 Mar 13; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 13.

Comparison of analytical methods for antibody conjugates with application in nuclear imaging - Report from the trenches.

Autor: Feiner IVJ; CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramon 182, 20014 San Sebastian, Spain., Longo B; Kosterlitz Centre for Therapeutics, University of Aberdeen, UK., Gómez-Vallejo V; CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramon 182, 20014 San Sebastian, Spain., Calvo J; CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramon 182, 20014 San Sebastian, Spain., Chomet M; Amsterdam UMC, VU University, Dept. of Radiology and Nuclear Medicine, De Boelelaan 1085c, 1117 HV Amsterdam, the Netherlands., Vugts DJ; Amsterdam UMC, VU University, Dept. of Radiology and Nuclear Medicine, De Boelelaan 1085c, 1117 HV Amsterdam, the Netherlands., Windhorst AD; Amsterdam UMC, VU University, Dept. of Radiology and Nuclear Medicine, De Boelelaan 1085c, 1117 HV Amsterdam, the Netherlands., Padro D; CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramon 182, 20014 San Sebastian, Spain., Zanda M; Kosterlitz Centre for Therapeutics, University of Aberdeen, UK; CNR-SCITEC, via Mancinelli 7, 20131 Milan, Italy., Rejc L; University of Ljubljana, Faculty of Chemistry and Chemical Technology, Večna pot 113, 1000 Ljubljana, Slovenia., Llop J; CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramon 182, 20014 San Sebastian, Spain; Centro de Investigación Biomédica en Red - Enfermedades Respiratorias (CIBERES), Spain. Electronic address: jllop@cicbiomagune.es.

Publikováno v: Nuclear medicine and biology [Nucl Med Biol] 2021 Nov-Dec; Vol. 102-103, pp. 24-33. Date of Electronic Publication: 2021 Aug 18.

Correction: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities.

Autor: Zhang Y; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Catalonia, 08193 Bellaterra, Spain. anna.roig@csic.es., García-Gabilondo M, Grayston A, Feiner IVJ, Anton-Sales I, Loiola RA, Llop J, Ramos-Cabrer P, Barba I, Garcia-Dorado D, Gosselet F, Rosell A, Roig A

Publikováno v: Nanoscale [Nanoscale] 2021 Feb 07; Vol. 13 (5), pp. 3306. Date of Electronic Publication: 2021 Feb 01.

Chemically Programmed Vaccines: Iron Catalysis in Nanoparticles Enhances Combination Immunotherapy and Immunotherapy-Promoted Tumor Ferroptosis.

Autor: Ruiz-de-Angulo A; Chemical Immunology Laboratory, CIC BioGUNE, Building 801A, Derio 48160, Spain., Bilbao-Asensio M; Department of Chemistry and Centre for NanoHealth, Swansea University, Singleton Park, Swansea SA2 8PP, UK., Cronin J; Swansea University Medical School, Institute of Life Science, Singleton Park, Swansea SA2 8PP, UK., Evans SJ; Swansea University Medical School, Institute of Life Science, Singleton Park, Swansea SA2 8PP, UK., Clift MJD; Swansea University Medical School, Institute of Life Science, Singleton Park, Swansea SA2 8PP, UK., Llop J; Radiochemistry and Nuclear Imaging Laboratory, CIC BiomaGUNE, Paseo Miramón 182, San Sebastián 20014, Spain., Feiner IVJ; Radiochemistry and Nuclear Imaging Laboratory, CIC BiomaGUNE, Paseo Miramón 182, San Sebastián 20014, Spain., Beadman R; Swansea University Medical School, Institute of Life Science, Singleton Park, Swansea SA2 8PP, UK., Bascarán KZ; Radiochemistry and Nuclear Imaging Laboratory, CIC BiomaGUNE, Paseo Miramón 182, San Sebastián 20014, Spain., Mareque-Rivas JC; Department of Chemistry and Centre for NanoHealth, Swansea University, Singleton Park, Swansea SA2 8PP, UK.

Publikováno v: IScience [iScience] 2020 Aug 26; Vol. 23 (9), pp. 101499. Date of Electronic Publication: 2020 Aug 26 (Print Publication: 2020).